Leading Pharma-Health-Insurance Assets Converge: Optimal 2025 Integrated Solutions to Be Unveiled at VBEF
The New “Ten National Insurance Provisions” have set forth new requirements for the deep integration of “health insurance + health management.” Driven by continuous breakthroughs from innovators, an increasing number of “medical-insurance innovation assets” with Chinese characteristics are emerging and demonstrating robust vitality in the global healthcare and pharmaceutical markets.
We observe that under the dual pressures of an aging population and the increasing prevalence of chronic diseases among younger demographics,Innovative Insurance for Individuals with Pre-existing ConditionsAs one of the innovative solutions driving synergistic integration, ChatGPT and DeepSeek have ignited a technological wave.AI-Driven Precision in Health Management Services、PersonalizationWelcoming More Breakthroughs,Big Data Is Reshaping Insurance Pricing and Risk Management...
To drive the value release of more integrated solutions for health management and health insurance, VCBeat will concurrently host an event during the 2025 VBEF Top 100 Future Healthcare & Pharma Exhibition (VBEF), to be held at the Suzhou International Expo Center from May 9 to 10.“Forum on Health Management and the Development of Health Insurance”, inviting leading national insurance companies, health insurance & health management innovators, and industry chain participants to jointly develop value integration solutions for health insurance and health management in 2025, exploring the optimal industry solution.
(Information statistics as of March 27; the agenda will be updated gradually)
Build Headline Connections, Find Resource Collaborations—Choose VCBeat VBEF First
Connecting Leading Healthcare and Insurance Enterprises to Discover New Models of “Medical-Insurance Integration” Cooperation
Forum InvitationPing An Health Insurance, Sunshine Insurance, ZhongAn Insurance, Pacific InsuranceMultiple leading domestic insurance companies share their insights, reflections, and practices from the forefront of the industry, putting into action the core philosophy of “insurance for the people.”
AlsoShangyong Technology, Mijian MedicalInnovative enterprises are leveraging AI and big data technologies to achieve refined risk control and healthcare management, unlocking greater possibilities for the insurance industry.
In addition, the VBEF concurrent forums also featureNational Healthcare Security Policy ExpertDeconstructing the Evolutionary Trends of Medical Insurance Cost Control and Healthcare Payment SystemsGlobal Leading Pharmaceutical CompanyThe Full-Link Ecosystem of Pharmaceuticals, Healthcare, and InsuranceLocal Government DepartmentsSharing Best Practices for Regional Implementation Across China for Industry Reference.
High-Quality Assets + High-Quality Buyers: Achieving Resource Matching in Health Management and InsurTech
To facilitate precise resource alignment, VCBeat VBEF concurrently hosts a series of N+ activities, including closed-door government-enterprise meetings, premium asset promotion sessions, and innovative product launches. By adopting an integrated “exhibition + forum + transaction” model, the event fosters deep connections between high-quality assets and global capital, local industrial chains, and end-user medical institutions, thereby empowering China’s high-quality medical and pharmaceutical innovations to bridge the gap from “innovative capacity” to “productive output.”
The exhibition facilitates diverse matchmaking:2025 VBEF Special Exhibition Area DesignCenter Stage (Thematic Roadshows, Product Launches), Innovative Product Showcase (Product Demos, Case Studies)、Innovative Assets Poster Exhibition (TOP 100 Investment Landscape, Resource Matchmaking)Three Major Value Domains: Accelerating the Value Multiplication of High-Quality Assets in China’s Medical and Pharmaceutical Innovation Through Innovative Models and Efficient Mechanisms.
Forum Decoding Trends:2 Main Forums, 4 Featured Forums, and 20+ Thematic Forums comprehensively cover the hot sectors of high-quality innovative assets in China’s healthcare and pharmaceutical industries. Over 300 industry leaders, academicians, experts, and corporate executives will discuss the growth poles of China’s healthcare industry, precisely identifying growth drivers for high-quality assets.
High-Efficiency Transaction Scenarios:Exhibiting companies can engage directly with international buyers, overseas distributors, and supply chain partners. Through on-site negotiations and demand-matching sessions, they can swiftly secure business opportunities in cross-border cooperation, technology introduction, and product distribution, thereby facilitating the integration of China’s high-quality innovative medical and pharmaceutical assets into the global industrial chain.
Welcome partners from all sectors of the industry to scan the QR code and register, enabling direct communication and collaboration discussions with innovative enterprises.
Limited-Time Early Bird Tickets: Hot Sale in Progress!
As low as69 yuan!(Deadline: March 31)
Free tickets available—limited quantity, first come, first served!
Share this article/poster to your Moments and collect 18 likes,
Add the Organizing Committee (Note: Ticket Benefits),
Get a ticket worth 399 yuan (excluding meals)!
Ms. Jing - Registration Inquiry for Conference Attendance
Mr. Weng - Registration Inquiry for Conference Attendance
(Click to view full-size image)
May 09 Medical Device Distributor Conference
May 09-10 Medical Device Design and Manufacturing Conference
May 09–10 Global Bio-Manufacturing Conference
May 10: Conference on Growth of New Products and New Channels in the Out-of-Hospital Market
Internet Hospital and Smart Hospital Forum, Pharmaceutical Company Digital Marketing Forum, Medical AI Large Model Application Innovation Forum, ITBT & AI Drug R&D Forum, Cardiovascular Disease Industry-Research Innovation Forum, Foreign Enterprise Digital Innovation and Development Forum, Minimally Invasive Surgery Industry Innovation and Development Forum, CGT Venture Capital and BD New Opportunities Forum, Precision Medicine and Molecular Diagnostics Industry Development Forum, Health Management and Health Insurance Development Forum, Ophthalmology Industry Innovation and Development Forum...
More Forums to Be Updated
2025 Future Healthcare 100 List Release Ceremony and Innovation Awards Ceremony
Matchmaking sessions, closed-door meetings, project roadshows, high-end business events, etc.
★Themed Exhibition Area★
Innovative Medical Device Products Exhibition, Medical Device Design and Manufacturing Exhibition, Digital Healthcare and Services Exhibition,
Bio-Manufacturing Themed Exhibition, Life Science Instrumentation Exhibition, Health Consumer Goods Collection Exhibition,
Regional Government Park Exhibition, International Exhibition Zone... More Themed Exhibition Zones to Be Updated
Exhibition Name:2025 VBEF Future Healthcare & Pharma Top 100 Exhibition
Exhibition Time:May 9–10, 2025
Exhibition Venue:China · Suzhou · International Expo Center
Exhibition Scale:16,000+ visits
(More partners to be confirmed. Stay tuned to VBEF for the latest updates.)
Organizer:VCBeat
Co-organized by:VCBeat New Medicine, ATLATL Dart Innovation Center, Enshe Capital, Guoke Hengtai, He Eye Hospital, Tan Zhen Capital
Forum Supporting Organizations:MathWorks, Pivotal bioVenture, Alibaba DAMO Academy, Anjieming, Aoruiji, Boson Quantum, Bohe Innovation Center, Deneng Medical, Dongmai Medical, Enshe Capital, Fanzhuo Group, Fuxin Sci-Tech Innovation, GeRui, Guotai Junan, He Eye Specialist Hospital, Hengxu Capital, Hunan Provincial Medical Device Industrial Park, Huamei Haolian, Huimei Digital Technology, Health Road, Jieshi Medical, JD Health, Jinghan New Materials, Legend Star, Linsheng Polymer, Lulutong Health, Lide Health, Mijian, Natrai, Ping An Good Doctor, Puchuang Medical, Ruisen Medical, Shangyong Technology, Taozi Health, Tonghe Litai, Tupai Medical, Weimei Health, Xiyi Medicine, Xikang Cloud Hospital, Xinhong Electronics, Yanyin Technology, Yishu Health, Yijiada Medical, Zhejiang Kayi, Knowledge Matrix, JLL, China Pharmaceutical University Suzhou Alumni Association
Supported by:Proxima Ventures, Boyuan Capital, Bencao Capital, Changfa Group, Chende Capital, Changling Capital, Daotong Investment, Panlin Capital, Danlu Capital, GTJA Investment, Sequoia China, Honghui Fund, Huagai Capital, Legend Capital, Matrix Partners China, Legend Star, Qingsong Capital, Qiming Venture Partners, Shenzhen Capital Group (SCGC), Shanghai Industrial Capital, Xianfeng Qiyun, Sunshine Ronghui Capital, Yuanhe Origin, Yuansheng Venture Capital, Yuanyi Capital
Supported Industrial Parks for the Ranking:Changping Life Valley Industrial Base, Optics Valley Bio-City / Wuhan Gaoke Medical Device Park, Haicheng Digital Healthcare Industrial Park, Jiangsu Medical Device Technology Industrial Park, Shanghai Free Trade Zone No. 1 Life Science and Technology Industrial Park, Zhongguancun (Tongzhou) Innovative Medical Translation Industrial Park (Yifang Health Valley)
Exhibition Supporting Media:21st Century Business Herald, E-Pharma Academy, MedWorld Device World, Bioon Valley, TouchBio, Cyzone, Big Health Pie, Haodeya, Huihui Yaoka, Jixiao 361, CN-Healthcare, Quick Doctor Ask, Bioon, Taidu TIMEDOO, Tansis Bio, Pedaily, Xiao Fan Zhuo, InfoXia, Yao Fangzhou, Yaoka Hui, YAOZH, Yi Gong Xue Ren, Yi Qian Yan, DXY, Pharma Manager, PharmaCube, Zhiyi Xun
